Literature DB >> 3257961

Properties of a broad spectrum beta-lactamase isolated from Flavobacterium meningosepticum GN14059.

T Fujii1, K Sato, E Yokota, T Maejima, M Inoue, S Mitsuhashi.   

Abstract

A broad substrate-spectrum beta-lactamase was purified from Flavobacterium meningosepticum GN14059. The purified enzyme gave a single protein band on SDS-polyacrylamide gel electrophoresis. The molecular weight was estimated to be about 30,000 and the isoelectric point was 5.1. The enzyme hydrolyzed various beta-lactam antibiotics including oxyiminocephalosporins and aztreonam. Relative rates, with cephaloridine as 100, were cephalothin 200, cefazolin 48, cefuroxime 153, cefotaxime 51, ceftazidime 20, ampicillin 26, carbenicillin 19, and aztreonam 20. The enzyme activity was inhibited by clavulanic acid, sulbactam, imipenem and cephamycins.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3257961     DOI: 10.7164/antibiotics.41.81

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  5 in total

1.  A beta-lactamase from Serratia marcescens hydrolyzing the 2-carboxypenam T-5575.

Authors:  N Matsumura; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1995-09       Impact factor: 5.191

2.  Cloning of a Chryseobacterium (Flavobacterium) meningosepticum chromosomal gene (blaA(CME)) encoding an extended-spectrum class A beta-lactamase related to the Bacteroides cephalosporinases and the VEB-1 and PER beta-lactamases.

Authors:  G M Rossolini; N Franceschini; L Lauretti; B Caravelli; M L Riccio; M Galleni; J M Frère; G Amicosante
Journal:  Antimicrob Agents Chemother       Date:  1999-09       Impact factor: 5.191

3.  Genetic-biochemical analysis and distribution of the Ambler class A beta-lactamase CME-2, responsible for extended-spectrum cephalosporin resistance in Chryseobacterium (Flavobacterium) meningosepticum.

Authors:  S Bellais; L Poirel; T Naas; D Girlich; P Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2000-01       Impact factor: 5.191

Review 4.  beta-Lactamases in laboratory and clinical resistance.

Authors:  D M Livermore
Journal:  Clin Microbiol Rev       Date:  1995-10       Impact factor: 26.132

5.  In vitro antibacterial activity and beta-lactamase stability of the new carbapenem SM-7338.

Authors:  Y Sumita; M Inoue; S Mitsuhashi
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-10       Impact factor: 3.267

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.